Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Healthequity (HQY) EBITDA Margin (2016 - 2026)

Healthequity (HQY) has 13 years of EBITDA Margin data on record, last reported at 24.43% in Q4 2025.

  • For Q4 2025, EBITDA Margin rose 2253.0% year-over-year to 24.43%; the TTM value through Oct 2025 reached 19.26%, up 1085.0%, while the annual FY2025 figure was 8.06%, 249.0% up from the prior year.
  • EBITDA Margin reached 24.43% in Q4 2025 per HQY's latest filing, down from 27.5% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 27.5% in Q3 2025 and bottomed at 16.14% in Q1 2022.
  • Average EBITDA Margin over 5 years is 4.52%, with a median of 2.38% recorded in 2024.
  • Peak YoY movement for EBITDA Margin: tumbled -1900bps in 2022, then skyrocketed 2253bps in 2025.
  • A 5-year view of EBITDA Margin shows it stood at 2.8% in 2021, then skyrocketed by 73bps to 0.76% in 2022, then surged by 875bps to 5.89% in 2023, then crashed by -68bps to 1.9% in 2024, then skyrocketed by 1187bps to 24.43% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 24.43% in Q4 2025, 27.5% in Q3 2025, and 16.3% in Q2 2025.